Hypovolaemic Shock: Pathophysiology of Absolute Volume Loss
Hypovolaemic shock occurs when a critical reduction in intravascular volume leads to inadequate tissue perfusion. The primary problem is loss of circulating volume, which reduces venous return, cardiac output, and oxygen delivery. This form of shock is most commonly associated with haemorrhage or severe fluid loss. Although compensatory mechanisms may initially maintain blood pressure, eventually these mechanisms fail and cellular hypoxia develops early. Hypovolaemic shock can progress rapidly if volume is not restored.
What You Need to Know
Hypovolaemic shock occurs when circulating intravascular volume is lost, meaning there is not enough blood volume returning to the heart to maintain an effective cardiac output. With reduced venous return, the ventricles fill less during diastole (reduced preload), so stroke volume falls. Even if the heart muscle is functioning normally, it cannot pump what it does not receive, so cardiac output drops and oxygen delivery to tissues becomes inadequate. Severity is influenced by both the amount of volume lost and the speed of loss, because rapid loss overwhelms compensation far earlier than gradual depletion.
The underlying volume loss can occur through several mechanisms, and while the causes differ, the physiological end-point is the same: insufficient preload and reduced forward flow. Common contributors include:
haemorrhage, including internal bleeding that may not be immediately obvious
gastrointestinal fluid loss (vomiting, diarrhoea) and renal losses (diuretics, osmotic diuresis)
burns and capillary leak where plasma shifts out of the vascular space
third spacing, where fluid moves into body compartments and becomes unavailable for circulation
The body responds quickly through sympathetic activation and neurohormonal pathways to preserve perfusion to the brain and heart. Tachycardia and peripheral vasoconstriction temporarily support arterial pressure, while the renin–angiotensin–aldosterone system and antidiuretic hormone promote sodium and water retention.
These responses help maintain blood pressure for a period, but they also reduce perfusion to skin, kidneys and the gastrointestinal tract and increase myocardial workload. If volume loss continues or is severe, compensation becomes inadequate, tissue perfusion falls, and cells shift toward anaerobic metabolism with lactate production and metabolic acidosis. Acidosis then further impairs cardiac contractility and vascular responsiveness, accelerating deterioration. Early volume replacement is therefore time-critical because it addresses the primary problem rather than relying on short-term compensation.
Beyond the Basics
Preload Reduction and Cardiac Output Failure
Preload refers to the volume of blood returning to the heart and filling the ventricles during diastole. In hypovolaemic shock, intravascular volume loss directly reduces preload, meaning the ventricles begin each contraction underfilled. Stroke volume falls as a result, not because the myocardium is weak, but because there is insufficient blood available to eject. This distinction is critical, as cardiac contractility may be preserved early in hypovolaemic shock, yet cardiac output still declines.
This mechanism differentiates hypovolaemic shock from cardiogenic shock, where preload may be normal or elevated but the heart cannot generate adequate forward flow. In hypovolaemia, restoring volume can rapidly improve cardiac output if intervention occurs before prolonged tissue injury develops.
Compensatory Vasoconstriction and Maldistribution of Flow
Systemic vasoconstriction is an early and powerful compensatory response mediated by sympathetic nervous system activation. Arterioles constrict to maintain blood pressure and redirect flow toward vital organs, particularly the brain and heart. As a result, tissues such as the skin, kidneys, and gastrointestinal tract receive significantly less perfusion.
While this redistribution initially preserves life, it comes at a cost. Prolonged vasoconstriction reduces oxygen delivery to peripheral tissues, impairs renal filtration, and compromises gut mucosal integrity. Reduced gut perfusion increases the risk of bacterial translocation and systemic inflammation, further destabilising the circulation. Over time, what began as a protective response becomes a contributor to organ dysfunction.
Microcirculatory Impairment
Hypovolaemic shock disrupts blood flow at the microcirculatory level. Reduced circulating volume leads to uneven capillary perfusion, with some capillary beds collapsing while others remain open. This creates patchy tissue oxygenation, where neighbouring cells may experience vastly different oxygen availability.
Even when macroscopic parameters, such as blood pressure, appear to improve after fluid resuscitation, microcirculatory flow may remain impaired. This explains why patients can continue to deteriorate despite “normal” vital signs. Persistent microcirculatory dysfunction limits oxygen extraction at the tissue level and contributes to ongoing cellular hypoxia.
Metabolic Consequences of Tissue Hypoxia
When oxygen delivery falls below cellular demand, oxidative phosphorylation in the mitochondria can no longer proceed at an adequate rate. Cells compensate by increasing glycolysis, but without sufficient oxygen the electron transport chain cannot accept electrons, so pyruvate is converted to lactate by lactate dehydrogenase. This allows regeneration of NAD⁺ so glycolysis can continue, but it is far less efficient, producing only 2 ATP per glucose molecule compared to around 30–32 ATP in aerobic metabolism. As a result, energy supply rapidly becomes inadequate for cellular needs.
Lactate accumulation results from both increased production and impaired clearance, particularly in the liver and kidneys where lactate is normally metabolised. As lactate and hydrogen ions accumulate, intracellular and extracellular pH falls, resulting in metabolic acidosis. This is not simply a laboratory abnormality, it directly disrupts cellular function.
At the vascular level, acidosis reduces the responsiveness of smooth muscle to catecholamines such as noradrenaline. Even when endogenous or administered vasopressors are present, receptor binding and downstream signalling are less effective. This results in persistent vasodilation and an inability to maintain adequate blood pressure.
As acidosis worsens, cardiac output falls further, systemic perfusion declines, and oxygen debt increases. This self-reinforcing cycle accelerates tissue injury and makes shock increasingly resistant to treatment, particularly if volume replacement is delayed.
Progression to Decompensated Shock
If hypovolaemia is not corrected, compensatory mechanisms eventually fail. Blood pressure drops, coronary and cerebral perfusion decline, and organ dysfunction becomes evident. The kidneys are often affected early due to their sensitivity to reduced flow, followed by neurological changes and myocardial ischaemia.
With sustained hypoperfusion, cellular injury becomes irreversible. Mitochondrial failure, membrane breakdown, and inflammatory amplification lead to multiorgan failure. At this stage, even aggressive resuscitation may not restore function, highlighting why early recognition and volume correction are central to survival in hypovolaemic shock.
As shock progresses, the microcirculation becomes increasingly dysfunctional, even if macrocirculatory parameters such as blood pressure are temporarily restored. Capillary flow becomes uneven, with areas of stagnation alongside regions of shunting, meaning oxygen delivery at the tissue level remains inadequate. Endothelial injury increases vascular permeability, allowing fluid to leak into the interstitial space and further reducing effective circulating volume. This not only worsens tissue hypoxia but also contributes to oedema, impairing oxygen diffusion and reinforcing the cycle of cellular injury and organ failure.
Clinical Connections
Hypovolaemic shock frequently presents before hypotension develops, as early changes reflect compensatory responses rather than circulatory collapse. Tachycardia occurs as the heart attempts to maintain cardiac output despite reduced preload, while peripheral vasoconstriction preserves central perfusion at the expense of skin, renal and gastrointestinal blood flow. This produces cool peripheries, delayed capillary refill and reduced urine output. Mental status changes, such as restlessness, anxiety or confusion, may indicate early cerebral hypoperfusion and should be treated as significant even when blood pressure appears normal.
Clinical assessment should focus on identifying evidence of volume loss and impaired perfusion, rather than relying on a single abnormal vital sign. Hypovolaemia should be considered in the context of trauma, haemorrhage, gastrointestinal losses, burns, perioperative bleeding or significant third-space fluid shifts. Urine output is a particularly sensitive indicator, as renal perfusion is reduced early during compensatory vasoconstriction and often declines before hypotension occurs.
Features that support early recognition include:
persistent tachycardia that does not resolve with analgesia or rest
narrowing pulse pressure due to increased systemic vascular resistance
reduced urine output despite ongoing fluid intake
cool, pale or mottled skin reflecting peripheral vasoconstriction
subtle neurological changes indicating reduced cerebral perfusion
These findings are most meaningful when interpreted together and tracked over time, rather than viewed in isolation.
Early identification of hypovolaemic shock allows intervention before decompensation occurs. Prompt restoration of circulating volume directly addresses the primary physiological disturbance and prevents progression to metabolic acidosis, myocardial depression and multiorgan dysfunction. Delayed recognition, particularly when masked by preserved blood pressure, significantly increases morbidity and mortality.
Concept Check
Why does reduced preload impair cardiac output in hypovolaemic shock?
How do compensatory mechanisms initially maintain blood pressure?
Why does vasoconstriction worsen tissue hypoxia over time?
How does metabolic acidosis contribute to circulatory collapse?
Why is hypotension a late sign of hypovolaemic shock?